The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer

Hum Pathol. 2018 Nov:81:245-254. doi: 10.1016/j.humpath.2018.06.035. Epub 2018 Jul 25.
No abstract available

Keywords: Imaging; Immunohistochemistry; Medullary thyroid cancer; Prostate-specific membrane antigen; Theranostics; Tissue microarray.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Adult
  • Antigens, Surface / analysis*
  • Biomarkers, Tumor / analysis*
  • Carcinoma, Neuroendocrine / immunology*
  • Carcinoma, Neuroendocrine / mortality
  • Carcinoma, Neuroendocrine / secondary
  • Carcinoma, Neuroendocrine / surgery
  • Databases, Factual
  • Female
  • Glutamate Carboxypeptidase II / analysis*
  • Humans
  • Immunohistochemistry
  • Lymphatic Metastasis
  • Male
  • Microvessels / immunology*
  • Microvessels / pathology
  • Middle Aged
  • Molecular Imaging
  • Netherlands
  • Positron-Emission Tomography
  • Progression-Free Survival
  • Risk Assessment
  • Risk Factors
  • Theranostic Nanomedicine* / methods
  • Thyroid Neoplasms / immunology*
  • Thyroid Neoplasms / mortality
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / surgery
  • Time Factors
  • Tissue Array Analysis

Substances

  • Antigens, Surface
  • Biomarkers, Tumor
  • FOLH1 protein, human
  • Glutamate Carboxypeptidase II

Supplementary concepts

  • Thyroid cancer, medullary